A Scoping Review of Antibiotic Prescribing Patterns Using the WHO AWaRe Classification in Diverse Healthcare Settings: A Global Perspective
Main Article Content
Abstract
ABSTRACT
Background: The World Health Organization’s (WHO) Access, Watch, and Reserve (AWaRe) classification is a pivotal tool for monitoring antibiotic consumption and promoting stewardship. Objective: This scoping review synthesizes findings from empirical studies employing the AWaRe framework to map global antibiotic prescribing patterns and identify key trends and challenges.
Methods: A focused analysis of seven peer-reviewed studies from diverse geographical regions (India, Denmark, Indonesia, England, Burkina Faso, Mozambique) and healthcare settings (outpatient, inpatient, community) was conducted. Data on AWaRe category proportions, adherence to the WHO target (≥60% Access antibiotics), commonly prescribed agents, and study recommendations were extracted and thematically analyzed.
Results: A stark contrast was observed between high-income countries (HICs) and low- and middle-income countries (LMICs). Studies from HICs (Denmark, England) demonstrated better alignment with the WHO target (55-61% Access antibiotics), supported by established stewardship programs and national AWaRe adaptation. In contrast, LMIC studies consistently reported suboptimal Access group usage (1.6%-38% in India, 31.6% in Indonesia) and a concerning predominance of Watch group antibiotics (37%-98.4%), predominantly third-generation cephalosporins like ceftriaxone. Excessive injectable use and low generic prescribing were additional problems identified in LMIC settings.
Conclusion: The AWaRe classification effectively reveals problematic prescribing patterns, highlighting a significant global inequity in rational antibiotic use. While HICs show progress through policy integration and monitoring, LMICs face systemic challenges including diagnostic limitations and empirical over-reliance on broad-spectrum agents. Successful implementation requires contextual adaptation of the AWaRe framework, strengthening of diagnostic and regulatory infrastructure, and its integration into sustainable, funded antimicrobial stewardship programs, particularly in resource-limited settings.
Article Details

This work is licensed under a Creative Commons Attribution 4.0 International License.
References
1. WHO. Who report on surveillance of antibiotic consumption. WHO Geneva, Switzerland; 2018.
2. Murray CJ, Ikuta KS, Sharara F, Swetschinski L, Aguilar GR, Gray A, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. The lancet. 2022;399(10325):629-55.
3. Sharland M, Pulcini C, Harbarth S, Zeng M, Gandra S, Mathur S, et al. Classifying antibiotics in the WHO Essential Medicines List for optimal use—be AWaRe. The Lancet Infectious Diseases. 2018;18(1):18-20.
4. Christina S, Nandeibam R, Sangma AA, Devi HS. Antibiotic‐prescribing patterns in outpatient departments from a tertiary care hospital in Manipur using WHO AWaRe classification. The Indian Journal of Medical Research. 2025;162(2):220.
5. Sinha I, Kanth K, Krishnamoorthy Y, Gopichandran V. Access–watch ratio based on access, watch, and reserve classification of antibiotics in public health facilities of Tamil Nadu. Indian Journal of Public Health. 2022;66(3):352-4.
6. Lutfiyati H, Thobari JA, Yasin NM, Ikawati Z. Evaluation of antibiotics in pediatrics using the defined daily doses method and the World Health Organization (WHO) access, watch, and reserve classification (AWaRe 2021): a cross-sectional study. Pan African Medical Journal. 2024;48(1).
7. Valia D, Ingelbeen B, Kaboré B, Karama I, Peeters M, Lompo P, et al. Use of WATCH antibiotics prior to presentation to the hospital in rural Burkina Faso. Antimicrobial Resistance & Infection Control. 2022;11(1):59.
8. Xavier SP, da Silva AMC, Victor A. Antibiotic prescribing patterns in pediatric patients using the WHO access, watch, reserve (AWaRe) classification at a quaternary hospital in Nampula, Mozambique. Scientific Reports. 2024;14(1):22719.
9. Anhøj J, Boel J, Olesen BR, Bak HB, Hellesøe A-MB, Thomsen K, et al. Analysis of antibiotic use patterns in Danish hospitals 2015–2021 using an adapted version of the who aware classification. BMJ Open Quality. 2022;11(4).
10. Budd E, Cramp E, Sharland M, Hand K, Howard P, Wilson P, et al. Adaptation of the WHO Essential Medicines List for national antibiotic stewardship policy in England: being AWaRe. Journal of Antimicrobial Chemotherapy. 2019;74(11):3384-9.
11. Sulis G, Adam P, Nafade V, Gore G, Daniels B, Daftary A, et al. Antibiotic prescription practices in primary care in low-and middle-income countries: a systematic review and meta-analysis. PLoS medicine. 2020;17(6):e1003139.